Trials / Completed
CompletedNCT00694148
Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NT 201 is a Botulinum Toxin Type A Preparation Free of Complexing Proteins. Injected Into the Muscle, NT 201 Causes a Reversible Local Relaxation of the Injected Muscle. Botulinum Toxin Type A is Widely Used for Aesthetic Treatment of Mimic Wrinkles. This Study Will Investigate the Safety and Efficacy of NT 201 in the Treatment of Glabellar Frown Lines.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Merz Pharmaceuticals GmbH · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
NT 201 is a Botulinum toxin type A preparation free of complexing proteins. Injected into the muscle, NT 201 causes a reversible local relaxation of the injected muscle. Botulinum toxin type A is widely used for aesthetic treatment of mimic wrinkles. This study will investigate the safety and efficacy of NT 201 in the treatment of glabellar frown lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NT 201 | A Botulinum neurotoxin type A, free of complexing proteins Detailed described in study protocol |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2008-06-10
- Last updated
- 2012-10-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00694148. Inclusion in this directory is not an endorsement.